Cancer Center Advertising Costs Rose From 2005 to 2014

Share this content:
Cancer Center Advertising Costs Rose From 2005 to 2014
Cancer Center Advertising Costs Rose From 2005 to 2014

THURSDAY, July 14, 2016 (HealthDay News) -- From 2005 to 2014 there was an increase in cancer center advertising expenditures, with the greatest relative growth in spending seen for internet display advertisements, according to a research letter published online July 11 in JAMA Internal Medicine.

Laura B. Vater, M.P.H., from Indiana University School of Medicine in Indianapolis, and colleagues conducted a descriptive analysis of cancer center advertising expenditures from Jan. 1, 2005, to Dec. 31, 2014. Data were obtained from Kantar Media.

The researchers found that 890 cancer centers in the United States advertised to the public from 2005 to 2014, with total advertising spending reaching $173 million in 2014. Inflation-adjusted spending increased for all types of advertising, with the greatest relative growth in spending seen for internet display advertisements, which increased from less than 1 percent to 5 percent of total advertising spending from 2005 to 2014. Twenty cancer centers accounted for 86 percent of total advertising spending in 2014, five of which were for-profit centers. The largest advertising expenditures (59 percent of total advertising spending by cancer centers) were seen for Cancer Treatment Centers of America, a for-profit center.

"For some patients and families, cancer center advertising may constitute a major source of information, raising concerns in view of evidence that the content of some advertising lacks balance," the authors write. "The effect of cancer center advertising on the quality and costs of cancer care should be better understood."

Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »